Oncology News

ESMO oncology news ensures that you're always kept up to date with the latest developments that affect you and your daily practice. Make sure you check these pages frequently, or sign up to our newsletter.

Filter

Date Title Topic
09 Sep 2017 ESMO 2017: Promising Response Rates in Patients with Metastatic TNBC Treated with Nivolumab After Induction Treatment Breast cancer - Cancer Immunology and Immunotherapy
09 Sep 2017 ESMO 2017: TIL Levels Signal Pembrolizumab Response in Metastatic TNBC Breast cancer - Cancer Immunology and Immunotherapy
09 Sep 2017 ESMO 2017: Overall Survival Benefit is Seen with Olaparib in Patients with Ovarian Cancer and TP53 Disruptive Mutation Status Gynaecologic malignancies - Anticancer agents & Biologic therapy
09 Sep 2017 ESMO 2017: Progression-free Rate Unaffected by Sequence of Cytoreductive Nephrectomy and Sunitinib in Patients with Synchronous mRCC Genitourinary cancers - Anticancer agents & Biologic therapy
09 Sep 2017 ESMO 2017 Press Release: Patients Feel Psycho-social Impact of Chemo More Acutely Than Physical Side Effects
09 Sep 2017 ESMO 2017 Press Release: Osimertinib Improves Progression-free Survival in Patients with EGFR Mutated Lung Cancer Lung and other thoracic tumours
09 Sep 2017 ESMO 2017 Media Alert: Hot Topic at ESMO 2017: Session Focuses on Adjuvant Chemotherapy Duration in Colon Cancer
09 Sep 2017 ESMO 2017 Press Release: “Triggers”: a New Tool to Assess Cancer Patients’ Palliative Needs Palliative and supportive care
09 Sep 2017 ESMO 2017 Press Release: Durvalumab Improves Progression-free Survival in Stage III Lung Cancer Lung and other thoracic tumours
09 Sep 2017 ESMO 2017 Press Release: Study Identifies Factors that Limit Work Ability of Young Adult Cancer Survivors
08 Sep 2017 ESMO 2017: Rucaparib Shows Clinical Benefit as Maintenance Therapy in Patients with Recurrent Ovarian Cancer Gynaecologic malignancies - Anticancer agents & Biologic therapy
08 Sep 2017 ESMO 2017: PD-L1 as a Prognostic Factor in Patients with Glioblastoma Central nervous system malignancies - Pathology/Molecular biology
08 Sep 2017 ESMO 2017: Patients with Platinum Sensitive Ovarian Cancer Maintan QoL During Maintenance Niraparib Therapy Gynaecologic malignancies - Anticancer agents & Biologic therapy
08 Sep 2017 ESMO 2017: Combined Nivolumab and Radiotherapy ± Temozolomide Is Safe in Patients With Newly Diagnosed Glioblastoma Central nervous system malignancies - Cancer Immunology and Immunotherapy
08 Sep 2017 ESMO 2017: Significant Clinical Activity Demonstrated with 177Lu-PSMA617 in mCRPC Genitourinary cancers